Literature DB >> 28369242

Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke.

E Mara Vollema1, William K F Kong1,2, Spyridon Katsanos1,3, Vasileios Kamperidis1,4, Philippe J van Rosendael1, Frank van der Kley1, Arend de Weger5, Nina Ajmone Marsan1, Victoria Delgado1, Jeroen J Bax1.   

Abstract

AIMS: The presence of hypo-attenuated leaflet thickening (HALT) and/or reduced leaflet motion on multi-detector row computed tomography (MDCT) has been proposed as a possible marker for early transcatheter aortic valve thrombosis. However, its association with abnormal valve haemodynamics on echocardiography (another potential marker of thrombosis) and clinical outcomes (stroke) remains unclear. The present study evaluated the prevalence of HALT on MDCT and abnormal valve haemodynamics on echocardiography. In addition, the occurrence of ischemic stroke and/or transient ischemic attack (TIA) was assessed. METHODS AND
RESULTS: A total of 434 patients (mean age 80 ± 7 years, 51% male) who underwent transcatheter aortic valve replacement (TAVR) were evaluated. Transcatheter valve haemodynamics were assessed on echocardiography at discharge, 6 months, and thereafter yearly (up to 3 years post-TAVR). The presence of HALT and/or reduced leaflet motion was assessed on MDCT performed 35 days [interquartile range 19-210] after TAVR in 128 of these 434 patients. Possible TAVR valve thrombosis was defined by mean transvalvular gradient ≥20 mmHg and aortic valve area (AVA) ≤1.1cm2 on echocardiography or by the presence of HALT or reduced leaflet motion on MDCT. The occurrence of ischemic stroke/TIA at follow-up was recorded. HALT and/or reduced leaflet motion was present in 12.5% of 128 patients undergoing MDCT, and was associated with a slightly higher mean transvalvular gradient (12.4 ± 8.0 mmHg vs. 9.4 ± 4.3 mmHg; P = 0.026) and smaller AVA (1.49 ± 0.39 cm2 vs. 1.78 ± 0.45 cm2, P = 0.017). Only one patient with HALT on MDCT revealed abnormal valve haemodynamics on echocardiography. At 3-year follow-up, abnormal valve haemodynamics on echocardiography were observed in 3% of patients. HALT on MDCT and abnormal valve haemodynamics on echocardiography were not associated with increased risk of ischemic stroke/TIA.
CONCLUSION: On MDCT, 12.5% of patients showed HALT or reduced leaflet motion, whereas only one of these patients had abnormal valve haemodynamics on echocardiography. Neither HALT nor increased transvalvular gradient were associated with stroke/TIA. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Echocardiography; Multi-detector row computed tomography ; Stroke; Thrombosis; Transcatheter aortic valve replacement

Mesh:

Year:  2017        PMID: 28369242     DOI: 10.1093/eurheartj/ehx031

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  20 in total

Review 1.  How to Image and Manage Prosthesis-Related Complications After Transcatheter Aortic Valve Replacement.

Authors:  Nina C Wunderlich; Jörg Honold; Martin J Swaans; Robert J Siegel
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

2.  The role of antiplatelet drug resistance in subclinical leaflet thrombosis following transcatheter aortic valve replacement.

Authors:  Hashrul N Rashid; Paul Thein; Arthur Nasis
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

3.  Haemodynamic prosthetic valve performance in patients with early leaflet thrombosis after transcatheter aortic valve implantation.

Authors:  Manuel Hein; Jan Minners; Nikolaus Jander; Philipp Breitbart; Christian Stratz; Gregor Pache; Franz-Josef Neumann; Philipp Ruile
Journal:  Clin Res Cardiol       Date:  2019-02-06       Impact factor: 5.460

Review 4.  Transcatheter aortic valve thrombosis: a review of potential mechanisms.

Authors:  Vrishank Raghav; Prem Midha; Rahul Sharma; Vasilis Babaliaros; Ajit Yoganathan
Journal:  J R Soc Interface       Date:  2021-11-24       Impact factor: 4.118

Review 5.  Transcatheter Aortic Valve Leaflet Thrombosis: Prevalence, Management, and Future Directions.

Authors:  Makoto Nakashima; Hasan Jilaihawi
Journal:  Curr Cardiol Rep       Date:  2021-11-11       Impact factor: 2.931

6.  Aortic valve function post-replacement of severe aortic stenosis by transcatheter procedure versus surgery: a systematic review and metanalysis.

Authors:  Barbara Ignatiuk; Guliz Erdem; Hani Jneid; Nikolaos Bonaros; Charbel Abi Khalil; Hiam Chemaitelly; Fabio Barilli; Mohamed El-Shazly; Jassim Al Suwaidi; Samar Aboulsoud; Markus Kofler; Lukas Stastny
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

7.  Coagulation derangement and risk factors for valve thrombosis following transcatheter aortic valve implantation.

Authors:  Tiffany Patterson; Harriet Hurrell; Jack Lee; Giulia Esposito; Utkarsh Dutta; Julia Grapsa; Nicholas Aroney; Fiyyaz Ahmed-Jushuf; Christopher Allen; Ronak Rajani; Rebecca Preston; Christopher Young; Gianluca Lucchese; Kiran Parmar; Beverley Hunt; Bernard D Prendergast; Simon R Redwood
Journal:  Open Heart       Date:  2021-06

8.  Subclinical Valve Thrombosis in Sutureless Bioprosthetic Valves.

Authors:  Bobby Yanagawa; Subodh Verma; C David Mazer
Journal:  J Am Heart Assoc       Date:  2017-08-21       Impact factor: 5.501

9.  Impact of leaflet thrombosis on hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: A meta-analysis.

Authors:  Zixin Tian; Tiejun Li; Shumei Ma
Journal:  Clin Cardiol       Date:  2020-01-20       Impact factor: 2.882

Review 10.  Leaflet immobility and thrombosis in transcatheter aortic valve replacement.

Authors:  Arnold C T Ng; David R Holmes; Michael J Mack; Victoria Delgado; Raj Makkar; Philipp Blanke; Jonathon A Leipsic; Martin B Leon; Jeroen J Bax
Journal:  Eur Heart J       Date:  2020-09-01       Impact factor: 35.855

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.